日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating CD16-Positive Monocyte-like Myeloid-Derived Suppressor Cells and Intermediate Monocytes Associated with Clinical and Immunological Complications in Pars Planitis Patients

循环中CD16阳性单核细胞样髓系来源抑制细胞和中间单核细胞与扁桃体周边部炎患者的临床和免疫并发症相关

Kosmaczewska, Agata; Przeździecka-Dołyk, Joanna; Ciszak, Lidia; Rojek-Gajda, Zofia; Frydecka, Irena; Turno-Kręcicka, Anna; Misiuk-Hojło, Marta; Pawlak, Edyta

miR-155-5p Silencing Does Not Alter BTLA Molecule Expression in CLL T Cells: Implications for Targeted Immunotherapy

miR-155-5p沉默不改变CLL T细胞中BTLA分子的表达:对靶向免疫治疗的启示

Kosmaczewska, Agata; Ciszak, Lidia; Andrzejczak, Anna; Tomkiewicz, Anna; Partyka, Anna; Rojek-Gajda, Zofia; Frydecka, Irena; Wołowiec, Dariusz; Wróbel, Tomasz; Bojarska-Junak, Agnieszka; Roliński, Jacek; Karabon, Lidia

Association of Genetic Variants at the CDKN1B and CCND2 Loci Encoding p27(Kip1) and Cyclin D2 Cell Cycle Regulators with Susceptibility and Clinical Course of Chronic Lymphocytic Leukemia.

CDKN1B 和 CCND2 位点的遗传变异与 p27(Kip1) 和细胞周期调节因子 Cyclin D2 的关联性及慢性淋巴细胞白血病的易感性和临床病程

Ciszak Lidia, Kosmaczewska Agata, Pawlak Edyta, Frydecka Irena, Szteblich Aleksandra, Wołowiec Dariusz

Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma - results of a prospective cohort study

编码共抑制分子BTLA的基因变异与接受透明细胞肾癌治疗的患者的生存率相关——一项前瞻性队列研究的结果

Tupikowski, Krzysztof; Partyka, Anna; Pawlak, Edyta A; Ptaszkowski, Kuba; Zdrojowy, Romuald; Frydecka, Irena; Hałoń, Agnieszka; Karabon, Lidia

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

CD86基因遗传变异对异基因造血干细胞移植后预后的影响

Karabon, Lidia; Markiewicz, Miroslaw; Chrobot, Karolina; Dzierzak-Mietla, Monika; Pawlak-Adamska, Edyta; Partyka, Anna; Koclega, Anna; Kyrcz-Krzemien, Slawomira; Frydecka, Irena

Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia

BTLA基因内的基因内变异影响慢性淋巴细胞白血病患者BTLA基因的mRNA表达,并赋予慢性淋巴细胞白血病易感性。

Karabon, Lidia; Partyka, Anna; Jasek, Monika; Lech-Maranda, Ewa; Grzybowska-Izydorczyk, Olga; Bojarska-Junak, Agnieszka; Pawlak-Adamska, Edyta; Tomkiewicz, Anna; Robak, Tadeusz; Rolinski, Jacek; Frydecka, Irena

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation

受体CTLA-4基因中的CT60G>A多态性可能导致异基因造血干细胞移植后发生急性移植物抗宿主病。

Karabon, Lidia; Markiewicz, Miroslaw; Partyka, Anna; Pawlak-Adamska, Edyta; Tomkiewicz, Anna; Dzierzak-Mietla, Monika; Kyrcz-Krzemien, Slawomira; Frydecka, Irena

Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression

类风湿性关节炎患者外周血CD4+ T细胞的激活和抑制潜能的改变与疾病进展相关。

Kosmaczewska, Agata; Ciszak, Lidia; Swierkot, Jerzy; Szteblich, Aleksandra; Wiland, Piotr; Frydecka, Irena

Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population

波兰人群中,抑癌分子ctla-4基因的变异与多发性骨髓瘤的易感性相关

Karabon, Lidia; Pawlak-Adamska, Edyta; Tomkiewicz, Anna; Jedynak, Anna; Kielbinski, Marek; Woszczyk, Dariusz; Potoczek, Stanisław; Jonkisz, Anna; Kuliczkowski, Kazimierz; Frydecka, Irena

Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression

晚期宫颈癌患者外周血T细胞中共刺激分子CD28和抑制分子CTLA-4表达失调提示存在与疾病进展相关的全身性免疫抑制。

Kosmaczewska, Agata; Bocko, Dorota; Ciszak, Lidia; Wlodarska-Polinska, Iwona; Kornafel, Jan; Szteblich, Aleksandra; Masternak, Anna; Frydecka, Irena